Friday, 06 December 2019

Generics News

  • Pfizer, Hisun launch generics joint venture in China

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

    Singapore: Pfizer and China's Zhejiang Hisun Pharmaceuticals, a leading Chinese pharmaceutical company, announced the launch of Hisun-Pfizer Pharmaceuticals, a joint venture formed between ...Read more

  • Teva launches generic of Abilify, antipsychotic drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 30 Apr, 2015

    Singapore: Teva Pharmaceutical has launched the generic equivalent to Abilify, aripiprazole tablets, an atypical antipsychotic medication, are approved for the treatment of schizophrenia an...Read more

  • Sun's generic of Takeda ulcer drug gets FDA nod

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2013

    Singapore: Indian pharmaceutical major, Sun Pharmaceutical Industries announced that the generic version of Prevacid by the company has received that final approval from the US FDA. The Am...Read more

  • Teva to pay $718 mn to apex tax body in Israel

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Nov, 2013

    Singapore: Israel-based Teva Pharmaceutical is going to pay $718 million to Israel Tax Authority to pay for the release of trapped profits, settling tax assessments for the years 2005-07 an...Read more

  • Sandoz gets FDA nod for MS generic drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 Apr, 2015

    Singapore: Sandoz, a Novartis company, has recieved USFDA approval of Glatopa, a first generic version of Teva's Copaxone (glatiramer acetate injection) for multiple sclerosis therapy. "Sa...Read more

  • Drug shortage forces FDA to approve cancer generic

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

    Singapore: The US FDA has provided its approval for a generic version of cancer drug Doxil that has been facing shortage due to manufacturing deficiencies. This generic version of the drug...Read more

  • Hong Kong to host international TCM exhibition, conference

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

    Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ) is organizing 12th International Conference and Exhibition of the M...Read more

  • Britain's MHRA recalls 16 Wockhardt medicines

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

    Singapore: UK's drug regulatory body, Medicines and Healthcare products Regulatory Agency (MHRA) has recalled 16 drugs manufactured by Wockhardt Ltd after identifying 'manufacturing deficie...Read more

  • Chinese planning agency to probe pharma prices

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2013

    Singapore: China's primary economic planning agency, the National Development and Reform Commission (NDRC) is in the process of investigating the costs and prices charged by drugmakers. Acc...Read more

  • Aurobindo recalls epilepsy drug lot in US

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 25 Nov, 2014

    Singapore: India-based Aurobindo Pharma in the US is recalling Gabapentin capsules, USP 300 mg 100-count bottles, at consumer level due to possible stashs of some empty capsules. USFDA has...Read more

  • Wockhardt restructures quality control team

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Sep, 2013

    Singapore: After being rapped by the US FDA and Indian drug regulator for lapses in good manufacturing practices (GMP), Indian drug major Wockhardt has now restructured its quality control ...Read more

  • GSK officials under criminal investigation in China

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

    Singapore: The Chinese police who have been investigating allegations of bribery against senior executives working at UK's leading multinational pharmaceutical company GlaxoSmithKline in Ch...Read more

  • Pneumonia kills a 5-year-old child every 30 secs: UN

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2013

    Singapore: Pneumonia remains the single biggest killer of children under the age of five globally, claiming the lives of more than one million girls and boys every year. However, the good n...Read more

  • Sanofi files first-of-a-kind suit against FDA

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Nov, 2013

    Singapore: Sanofi has filed a lawsuit against the US FDA in hopes of preventing the regulatory agency from releasing packaging information of its newly approved over-the-counter (OTC) aller...Read more

  • “Chinese generics market has no strategy for international players”

    Generics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 17 Nov, 2014

    Singapore: In the last one year, Actavis has been aggressive in expanding its presence in Asia and the company was on an acquisition spree. Marking a direct presence in Asia, Actavis launch...Read more

  • US FDA imposes import alert on Ranbaxy drugs

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2013

    Singapore: The US FDA has issued an alert on import of Ranbaxy Laboratories drug products that are manufactured at its plant in Mohali, India. The firm will remain on the import alert unt...Read more

  • Apollo Pharmacy cautions against Ranbaxy drugs' use

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

    New Delhi: Spelling further problems for India's pharma giant Ranbaxy and its Japanese owners Daiichi Sankyo, Apollo Pharmacy has issued a 'cautionary advisory' against the use of all drugs...Read more

  • Asian generic companies focus more on market expansion

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2015

    Singapore: A Frost & Sullivan (F&S) analysis finds that the Asian generic market is expected to grow at a compound annual growth rate of 17-18 percent between 2014 and 2018. The tea...Read more



Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls